Analyst Christopher Liu works at LEERINK and is focused on the Healthcare sector with 14 price targets and ratings documented since 2020 spanning on 3 stocks. Analyst's average stock valuation to be materialised ratio is 16.67% with an average time for price targets to be met of 21.67 days.
Most recent stock forecast was given on COGT, at 13-Jun-2022.
Christopher Liu best performing recommendations are on COGT.
The best stock recommendation documented was for COGT at 6/13/2022. The price target of $15 was fulfilled within 65 days with a profit of $6.26 (71.62%) receiving and performance score of 11.02.
Average potential price target upside
Currently, out of the existing stock ratings of Christopher Liu - 1250 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
20
$9.57 (91.75%)
18
2 months 26 days ago
1/4 (25%)
$7.62 (71.78%)
65
Buy
22
$11.57 (110.93%)
22
9 months 14 days ago
0/6 (0%)
$13.22 (166.49%)
Buy
15
$0.57 (3.95%)
20
9 months 18 days ago
1/2 (50%)
$6.63 (62.68%)
65
Buy
19
$8.57 (82.17%)
24
1 years 7 months 15 days ago
1/5 (20%)
$13.94 (87.42%)
124
